FDA Investigator Francis J Eng

Francis J Eng has inspections in 11 countries as of 20 Sep 2023. Francis J Eng has collaborated with a combinined 3217 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
300
Last Inspection Date:
20 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
100006759
Country:
China, United States of America, Taiwan, Hong Kong, Indonesia, Germany, Japan, United Kingdom of Great Britain and Northern Ireland, Malaysia, Switzerland
Co-Investigator(s):
A Williams, Abraham M Maekele, Adam S Freeman, Alla Dubrovsky, Althea A Williams, Amanda S Zorn, Anderson, Andre S Lamontagne, Andrea P Scott, Angel K Sandhu, Anita R Michael, Ashleigh P Barkans, Ashley A Mutawakkil, Barbara J Rincon, Brenda L Reihing, Brittany D Mccracken, Byungja E Marciante, Calvin K Cook, Camerson E Moore, Carl Lee, Carol A Llewellyn, Catherine J Laufmann, CDR Sean T Creighton, Christine I Shaw, Christine M Parmentier, Claudette D Brooks, Daniel J Lahar, David P Vanhouten, Dawn M Braswell, Deborah A Greco, Debra L Boyd Seale, Dejon N Harris, Dennis G Kawabata, Donald B Mckechnie, Donna Ltartaglino Besone, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Durell L Giles, Dustin R Abaonza, Elizabeth A Dakan, Elmiloudi M Sarhrani, Emil P Wang, JD, Emir Galevi, Emma R Schaefer, Eric M Padgett, Eric W Anderson, Felix J Marrero, Finn A Slizza, Francis Je, Francis Jeng Investigator, Frank J Marciniak, Frank P Bianco, Franois J Eng, Gamal A Norton, Gary L Zaharek, Gene D Arcy, George T Allen, Jr, Greg K Keshishyan, Gregson A Joseph, Harperd, Iris C Macinnes, Jacqueline M Cleary, Jacqueline S Warner, James A Lane, James D Hildreth, James D Planchon, James E Frye, James R Fleckenstein, James R Montero, Janet Pulver, Janete F Guardia, Jeffrey M Watson, Jeffrey W Shrifter, DPM, Jesse A Vazquez, Jessie E Morris, Jocelyn C Turner, Jocelyn E Massey, Jocelyn E Sparks, Jocelyn T Ramos, John A Sciacchitano, John E Emmert, Jolene S Hedgecock, Joseph A Seitz, Joseph C Teixeira, Joseph L Despins, PhD, Juan A Morales, Jude C Dikes, Judith A Paterson, Justina O Tam, Kari M Johansen, Kavita K Lalwani, Kellie L Thommes, RN, Kelly D Sheppard, Kelvin Cheung, Kenneth S Boehnen, Kenya Destin, Kham Phommachanh, Kimberly L Anderson, Kimberly L Pruszko, Kimberly Lewandowski Walker, Kingj, Kirtida Patel, Kwong P Lee, Lance M De Souza, MBA, Laverne Kimble, Leighton K Ngai, Leo J Lagrotte, Leonard H Lavi, Li Li, Linda Linh T Nguyen, Linda Linhn Adams, Linda S Shook, Lisa D Cash, Lori J Silverstein, Lorna F Jones, Lydia S Chan, Mageet, Maida Henesian (NMI), Marie K Kinkade, Marijo B Kambere, PhD, Mark E Chan, Mark K Tseng, Mary R Hole, Matthew A Walburger, Matthew B Casale, Max Lager, Mei Chen Mu, Miaja Umaedi, Michael A Charles, Michael J Nerz, Michael P Sweeney, Minh D Phan, Niraj R Mehir, Niraj R Mehta, PhD, Paul M Kawamoto, Perry H Gambrell, Peter Abel, Peter R Lenahan, Quynh H Strandberg, Randall F Albright, Rebecca T Davis, Richard Jay Tucker, RS, Rodney D Combs, Rosanna M Goodrich, Roy Baby, Samuel K Gibbons, Jr, Sara M Richardson, Sarah A Hassas, Scott A Nabe, Scott K Zika, Sean R Moynihan, MPH, Seema S Singh, Selene T Torres, Sergio Chavez (NMI), Seth A Mailhot, Shafiq S Ahadi, Shaquenta Y Perkins, Sheri N Rohlf, Sherri J Jackson, Sherri N Rohlf, MD, Sonya L Karsik, Stanley B Eugene, BS, BME, State Agency, Stephen D Eich, Stephen R Souza, Steven D Kehoe, Stuart W Russell, Suyang Qin, Suzanne M Healy, Suzie L Kent, Thai T Duong, Thomas A Peter, Thomas E Friel, Timothy C Grome, Trang N Cox, Trudy R Papson, Vickie L Anderson, Virgilio F Pacio, CSO, Vivian Garcia, Wendy Dela Torre, William D Bassett, Jr, William S Vitale, Yehualashet A Gessesse, Yvette Mlacour Davis

Francis J Eng's Documents

Publish Date Document Type Title
November, 2012 FDA 483 Pine Moon Electronics (Shenzhen) Co., Ltd. - Form 483, 2012-11-30
March, 2011 FDA 483 Iridex Corporation - Form 483, 2011-03-17
November, 2011 FDA 483 Promedical Products Co., Ltd. - Form 483, 2011-11-04
July, 2011 FDA 483 Trimedyne Inc - Form 483, 2011-07-22
September, 2000 EIR Alza Corp - EIR, 2000-09-07
September, 2003 EIR Iridex Corporation - EIR, 2003-09-24
April, 2013 FDA 483 Hubei Weikang Protective Products Co., Ltd. - Form 483, 2013-04-04
August, 2009 FDA 483 Penumbra Inc. - Form 483, 2009-08-28
December, 2002 FDA 483 Calix, Inc. - Form 483, 2002-12-17
September, 2013 FDA 483 Joinn Laboratories Co. Ltd. - Form 483, 2013-09-20
April, 2005 FDA 483 Varian Medical Systems, Inc. - Form 483, 2005-04-21
December, 2006 EIR Wavelight GmbH - EIR, 2006-12-20
September, 2013 FDA 483 Pharmaron - Form 483, 2013-09-13
September, 2000 FDA 483 Alza Corp - Form 483, 2000-09-07
November, 2002 FDA 483 3D Systems, Inc. - Form 483, 2002-11-04
April, 2000 FDA 483 SDL, Inc - Form 483, 2000-04-14
December, 2006 FDA 483 Wavelight GmbH - Form 483, 2006-12-20
August, 2012 FDA 483 Gerresheimer Medical Plastic Systems Dongguan Co., Ltd. - Form 483, 2012-08-17
January, 2010 FDA 483 Sciton Inc. - Form 483, 2010-01-13
April, 2013 EIR Hubei Weikang Protective Products Co., Ltd. - EIR, 2013-04-04

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more